Source link : https://www.newshealth.biz/health-news/when-to-de-escalate-tnbc-treatment/
When Erin Reardon, MD, started the doxorubicin phase of her neoadjuvant chemotherapy, she was already convinced she had crossed the threshold into overtreatment for her stage II, node-negative triple-negative breast cancer (TNBC). The harsh chemotherapy known as the “Red Devil” is part of the standard 1-year protocol for patients with stage II or III TNBC. […]
Author : News Health
Publish date : 2025-02-13 10:43:56
Copyright for syndicated content belongs to the linked Source.